IT_twi001t3122980.jpg

Nunaps!

Perceive Things Unperceived
 
IT_tcp010t005407.jpg

OUR MISSION

To Benefit Humans by Innovating Therapeutics for Diseases

IT_twi001t3245053.jpg

OUR VISION

Global Leading Player in Neuro Digital Therapeutics

About Us

We take pride in our in-house convergence science, technology and clinical professionals comprised of neuroscientists, neurologists, psychologists, AI scientists, software engineers and clinical trial managers.

It enables us bring neuroscience, medicine and IT together to change how medicine is designed and delivered.

 

We are building a platform to identify target biomarkers and develop novel digital therapeutics to treat or manage various neuropsychological disorders.

 

We have initiated a pivotal clinical trial of our first product, Nunap Vision, which provides visual perceptual training to treat visual field defects caused by brain damage. It is the first digital therapeutics clinical trial approved by MFDS in South Korea.

Nunapsians

Nunaps stands for Neuron and Synapse, which are key elements that form the basis of our brain. We, Nunapsians, are people who explore the roots of the brain. With constant challenges and passion, we will give new hopes and values to those suffering from diseases.

대표님 사진.jpg

Kang, Dong Wha

Chief Executive Officer

이은재 이사.tif

Lee, Eun Jae

Chief Medical Officer

최하균.jpg

Choi, Ha Gyun

Senior Software Engineer

 

황수영사진.jpg

Whang, Soo Young

Neuroscience Researcher

김지영 사원_edited_edited.jpg

Kim, Ji Yeong

Clinical Research Coordinator

조규석+전무님.png

Cho, Kyu Sok

Chief Financial Officer

김용환 소장.png

Kim, Yong Hwan

Head of Research

류영회 선임.jpg

Ryu, Yong Hoe

Software Engineer

김은지사진.jpg

Kim, Eun Ji

Clinical Research Coordinator

김유진_증명사진.JPG

Kim, Yu Jin

Neuroscience Researcher

하대환이사사진.jpg

Hah, Tae Hwan

Chief Technology Officer

조문주_사진.jpg

Cho, Moon Ju

Head of Clinical Trial Management

홍락균사진.jpg

Hong, Rak Kyeun

Neuroscience Researcher

최예슬사진.jpg

Choi, Ye Seul

Neuroscience Researcher

이지현 이사.png

Lee, Jee Hyun

VP of People and Culture

이유주 책임.png

Lee, Yu Ju

Senior UX/UI Designer

 

조주미사진.jpg

Cho, Ju Mi

Financial Manager

노수미사진.jpg

Noh, Su Mi

QA/RA Manager

서기현.jpg

Seo, Gi Hyeon

MD, Expert Advisor

장순기사진.jpg

Jang, Soon Gi

Senior QA/RA Manager

 

이현석사진.jpg

Lee, Hyun Seok

Neuroscience Researcher

김지현 사원.png

Kim, Ji Hyun

IT Planner

 

Science

뉴냅스 이미지-Science 및 Perceptual Learning.JPG

PERCEPTUAL LEARNING

Perceptual learning is defined as experience- or training-dependent performance improvements on a sensory task and is regarded as a manifestation of adult plasticity. In particular, visual perceptual learning (VPL) has attracted attention because of its benefits for visual perceptual ability, and there have been continuous endeavors to use VPL in clinical settings, such as to treat amblyopia, presbyopia, and stroke, and sports settings to enhance sports performance.

Recent Selected Publications

01

Jeong S, Lee EJ, Kim YH, Woo JC, Ryu OW, Kwon M, Kwon SU, Kim JS, Kang DW. Deep Learning Approach Using Diffusion-weighted Imaging to Estimate the Severity of Aphasia in Stroke Patients. J Stroke (in press)

02

Kim BJ, Jang SK, Kim YH, Lee EJ, Chang JY, Kwon SU, Kim JS, Kang DW. Diagnosis of Acute Central Dizziness with Simple Clinical Information Using Machine Learning. Front Neurol 2021 Jul 12;12:691057. 

03

Kim H, Lee Y, Kim YH, Lim YM, Lee JS, Woo J, Jang SK, Oh YJ, Kim HW, Lee EJ, Kang DW, Kim KK. Deep Learning-Based Method to Differentiate Neuromyelitis Optica Spectrum Disorder From Multiple Sclerosis. Front Neurol 2020 Nov 30;11:599042. 

04

Jang SK, Chang JY, Lee JS, Lee EJ, Kim YH, Han JH, Chang DI, Cho HJ, Cha JK, Yu KH, Jung JM, Ahn SH, Kim DE, Sohn SI, Lee JH, Park KP, Kwon SU, Kim JS, Kang DW; KOSNI Investigators. Reliability and Clinical Utility of Machine Learning to Predict Stroke Prognosis: Comparison with Logistic Regression. J Stroke 2020 Sep;22(3):403-406. 

05

Lee H, Lee EJ, Ham S, Lee HB, Lee JS, Kwon SU, Kim JS, Kim N, Kang DW. Machine Learning Approach to Identify Stroke Within 4.5 Hours. Stroke 2020 Mar;51(3):860-866.

06

Choi MJ, Kim H, Nah HW, Kang DW. Digital Therapeutics: Emerging New Therapy for Neurologic Deficits after Stroke. J Stroke 2019 Sep;21(3):242-258.

07

Kim YH, Cho AH, Kim D, Kim SM, Lim HT, Kwon SU, Kim JS, Kang DW. Early Functional Connectivity Predicts Recovery from Visual Field Defects after Stroke. J Stroke 2019 May;21(2):207-216.

08

Kang DW, Kim D, Chang LH, Kim YH, Takahashi E, Cain MS, Watanabe T, Sasaki Y. Structural and Functional Connectivity Changes Beyond Visual Cortex in a Later Phase of Visual Perceptual Learning. Sci Rep 2018 Mar 26;8(1):5186.

09

Lee EJ, Kim YH, Kim N, Kang DW. Deep into the Brain: Artificial Intelligence in Stroke Imaging. J Stroke 2017 Sep;19(3):277-285. 

10

Kim BJ, Kim YH, Kim N, Kwon SU, Kim SJ, Kim JS, Kang DW. Lesion location-based prediction of visual field improvement after cerebral infarction. PLoS One 2015 Nov 25;10(11):e0143882.

11

Lim JS, Kang DW. Stroke connectome and its implications for cognitive and behavioral sequela of stroke. J Stroke 2015 Sep;17(3):256-67.

12

Kim YH, Kang DW, Kim D, Kim HJ, Sasaki Y, Watanabe T. Real-time strategy video game experience and visual perceptual learning. J Neuroscience 2015 Jul 22;35(29):10485-92.

 
 
물결 모양의 추상 배경

Pipeline

Neurology​

Ophthalmology

News

"디지털 치료제를

개발하는 의사"

"뉴냅스, 시리즈A

50억원 투자유치"

뉴냅스, "디지털 치료제

​국내 첫 임상"

 
 
캐주얼 미팅

Contact

11F Asan Institute for Life Sciences, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, Republic of Korea